Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.680
-0.080 (-1.68%)
May 4, 2026, 4:00 PM EDT - Market closed
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $274.72 million as of May 4, 2026. Its market cap has increased by 42.36% in one year.
Market Cap
274.72M
Enterprise Value
158.27M
1-Year Change
42.36%
Ranking
Category
Stock Price
$4.68
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $274.72M, a decrease of -51.41%. That is a compound annual growth rate of -12.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 279.41M | -8.50% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 290.11M |
| Protara Therapeutics | 287.73M |
| C4 Therapeutics | 284.93M |
| Editas Medicine | 283.83M |
| Cellectis | 283.24M |
| Eledon Pharmaceuticals | 280.32M |
| LENZ Therapeutics | 278.43M |
| Coherus Oncology | 277.59M |